- Home
- KYMR vs VRE Comparison
KYMR vs VRE Comparison
Compare KYMR & VRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- VRE
- Stock Information
- Founded
- KYMR 2015
- VRE 1949
- Country
- KYMR United States
- VRE United States
- Employees
- KYMR N/A
- VRE N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- VRE Real Estate Investment Trusts
- Sector
- KYMR Health Care
- VRE Real Estate
- Exchange
- KYMR Nasdaq
- VRE Nasdaq
- Market Cap
- KYMR 1.8B
- VRE 1.6B
- IPO Year
- KYMR 2020
- VRE 1994
- Fundamental
- Price
- KYMR $30.53
- VRE $15.64
- Analyst Decision
- KYMR Buy
- VRE Buy
- Analyst Count
- KYMR 13
- VRE 4
- Target Price
- KYMR $56.69
- VRE $18.50
- AVG Volume (30 Days)
- KYMR 762.3K
- VRE 594.6K
- Earning Date
- KYMR 05-09-2025
- VRE 04-23-2025
- Dividend Yield
- KYMR N/A
- VRE 1.85%
- EPS Growth
- KYMR N/A
- VRE N/A
- EPS
- KYMR N/A
- VRE N/A
- Revenue
- KYMR $47,072,000.00
- VRE $279,630,000.00
- Revenue This Year
- KYMR $16.24
- VRE $0.97
- Revenue Next Year
- KYMR $22.41
- VRE $1.47
- P/E Ratio
- KYMR N/A
- VRE N/A
- Revenue Growth
- KYMR N/A
- VRE 3.92
- 52 Week Low
- KYMR $19.45
- VRE $13.84
- 52 Week High
- KYMR $53.27
- VRE $18.85
- Technical
- Relative Strength Index (RSI)
- KYMR 53.88
- VRE 47.08
- Support Level
- KYMR $28.28
- VRE $15.50
- Resistance Level
- KYMR $35.98
- VRE $15.96
- Average True Range (ATR)
- KYMR 2.14
- VRE 0.40
- MACD
- KYMR 0.01
- VRE 0.02
- Stochastic Oscillator
- KYMR 50.71
- VRE 42.65
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About VRE Veris Residential Inc.
Veris Residential Inc is a fully-integrated, self-administered and self-managed real estate investment trust (REIT). The company owns and operates a real estate portfolio comprised predominantly of multifamily rental properties located mainly in the Northeast and Class A office properties. The company performs substantially all real estate management, leasing, acquisition and development on an in-house basis. The properties are in three states in the Northeast, plus the District of Columbia. The company operates in two industry segments multifamily real estate & services and commercial & other real estate. The majority of revenue is from Multifamily real estate services.